Results for "consumer data right"
381-390 of 537 results for 'consumer data right'
Important developments for offshore diagnostic testing
In Ariosa Diagnostics, Inc & Ors v Sequenom, Inc [2021] FCAFC 101, the Full Federal Court delivered significant clarity for companies who provide or conduct diagnostic tests. ...
Four key ways technology will help companies meet their decarbonisation goals
Companies know they have to change the way they operate if they're going to reach net zero by 2050. In this Insight, we explore four key ways technology can help meet decarbonisation goals, drawing on examples discussed in our recent webinar 'Leveraging technology to accelerate decarbonisation'. ...
APRA releases the final version of Prudential Standard CPS 511 (Remuneration) with further regulation of remuneration disclosures to follow
APRA has released the final version of its prudential standard on remuneration (CPS 511), seeking to regulate incentive structures across all APRA-regulated entities. ...
Final report on review of Australia’s patent system
The Federal Government has released the final report on the review of the accessibility of patents for small and medium sized enterprises (SMEs), which follows the phasing-out of the innovation patent system in Australia. ...
Swiss claims and skinny labels: Full Federal Court considers infringement
An enlarged bench of the Full Federal Court has considered the principles applying to infringement of Swiss-style claims, with the decision potentially limiting the application of Swiss-style claims in the context of so-called second medical use patents, where the allegedly infringing products are ʽskinny-labelled’. ...
Moored in the Marina: the Federal Circuit Court refuses to imply a licence restriction for the use of sailing footage
The Federal Circuit Court provides a fresh reminder of the need for businesses in the creative industry to agree and clearly document positions on intellectual property (IP). ...
Down-scheduling CBD and growing Australia's cannabis industry
The Therapeutics Goods Administration is proposing amendments to the Poisons Standard to permit pharmacists to sell low-dose cannabidiol (CBD) products without a prescription. Businesses intending to import, manufacture and supply cannabis products in the Australian market should monitor these developments closely. ...
Rokt unsuccessful in the Full Court
The Full Court in Rokt Pte Ltd v Commissioner of Patents [2018] FCA 1988 reversed the decision of the trial judge, finding for the Commissioner of Patents that Rokt's digital advertising systems and methods invention does not constitute patentable subject matter. The decision further clarifies the patentability of computer-implemented inventions at Australian law. ...